Patent · US Expired

Compounds

US6734183B2 · kind B2 · utility

2Cited by
10References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 21, 2001
Grant dateMay 11, 2004
Priority date—
Expiry dateFeb 21, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the formula I useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.